Mach-1 Financial Group’s Globus Medical GMED Stock Holding History

Mach-1 Financial Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	–	–	167
2021 Q1	$0	Buy	+1	New	+$63	﹤0.01%	188

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Mach-1 Financial Group's GMED Position: Q2 2021 in Review

Mach-1 Financial Group sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 1 share.

Mach-1 Financial Group first reported a position in GMED in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

Mach-1 Financial Group reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
Mach-1 Financial Group sold 1 Globus Medical share in Q2 2021.
Mach-1 Financial Group first reported a position in Globus Medical in Q1 2021 and held it in 1 quarter.
Mach-1 Financial Group's Globus Medical position peaked at $0 in Q1 2021.
354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on Mach-1 Financial Group's 13F filing for Q2 2021, filed 4 Aug 2021.